It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Outset Medical Inc (OM) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.17, or 3.17%, to $5.54. The Outset Medical Inc has recorded 6,937 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Outset Medical to Present at Upcoming Investor Conferences.
Outset Medical Inc is listed on the NASDAQ in the Healthcare sector while operating in the Medical Devices industry. At the end of the last regular session, the stock closed at $5.37 and fluctuated between $5.51 as its day high and $5.17 as its day low. The current market capitalization of Outset Medical Inc is $269.57M. A total of 0.92 million shares were traded on the day, compared to an average of 1.30M shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, OM has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 545 shares. Over the last 12 months, there were 50 BUYs and 70 SELLs from insiders. Insiders purchased 788,559 shares during that period but sold 360,376.
In the most recent transaction, Williamson Steven S. sold 3,584 shares of OM for 4.76 per share on Nov 16. After the transaction, the Chief Commercial Officer now owns 112,994 company shares. In a previous transaction on Nov 16, Trigg Leslie sold 3,175 shares at 4.76 per share. OM shares that Chair and CEO owns now total 403,287.
Among the insiders who sold shares, Ahmed Nabeel disposed of 1,643 shares on Nov 16 at a per-share price of $4.76. This resulted in the Chief Financial Officer holding 87,528 shares of OM after the transaction. In another insider transaction, Brottem John L. sold 1,431 shares at $4.76 per share on Nov 16. Company shares held by the General Counsel now total 56,151.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for OM in the last 3 months, the mean price target is $7.40 with high estimates of $14.00 and low estimates of $3.00. In terms of 52-week highs and lows, OM has a high of $30.55 and a low of $2.90.
As of this writing, OM has an earnings estimate of -$0.61 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.55 per share and a lower estimate of -$0.67. The company reported an EPS of -$0.69 in the last quarter, which was 9.20% higher than expectations of -$0.76.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. OM’s latest balance sheet shows that the firm has $339.49M in Cash & Short Term Investments as of fiscal 2021. There were $37.81M in debt and $51.70M in liabilities at the time. Its Book Value Per Share was $3.03, while its Total Shareholder’s Equity was $374.08M.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OM is Buy with a score of 3.57.